Plant-Based Bioactive Compounds and Their Role in Sustainable Antifungal and Antimicrobial Drug Discovery

Janardhan Namdeo Nehul

Department of Botany, Dadapatil Rajale College of Science, Adinathnagar, Tal-Pathardi, Dist- Ahmednagar (M.S.), India

Corresponding Author Email: jnnehul@gmail.com

DOI : https://doi.org/10.51470/ABF.2026.5.1.41

Abstract

Keywords

Download this article as:

1. Introduction

Antimicrobial resistance (AMR) has emerged as one of the most serious global public health threats of the twenty-first century. The extensive and uncontrolled use of antibiotics and antifungal drugs has accelerated the evolution of resistant microbial strains, reducing the effectiveness of existing therapeutic agents. According to the World Health Organization (WHO), multidrug-resistant pathogens are responsible for increasing morbidity, mortality, and healthcare costs worldwide. The rapid spread of resistant bacterial and fungal infections has intensified the need for novel, safe, and sustainable antimicrobial agents [1]. Medicinal plants have been used for centuries in traditional healthcare systems for the treatment of infectious diseases. Plant-derived bioactive compounds possess immense pharmacological potential due to their structural diversity and broad-spectrum biological activities. Secondary metabolites synthesized by plants function as natural defense molecules against microbial pathogens, environmental stress, and herbivorous organisms. These compounds exhibit antibacterial, antifungal, antiviral, antioxidant, anti-inflammatory, and anticancer properties.

Plant-based bioactive compounds offer several advantages over synthetic drugs, including lower toxicity, biodegradability, eco-friendliness, and reduced environmental impact. Furthermore, phytochemicals often exhibit multitarget mechanisms of action, minimizing the risk of resistance development. Recent technological advancements in phytochemical screening, chromatography, metabolomics, molecular docking, and nanobiotechnology have facilitated the exploration of medicinal plants as valuable sources of antimicrobial drug candidates [2-3]. The present review focuses on the role of plant-derived bioactive compounds in sustainable antifungal and antimicrobial drug discovery. Major classes of phytochemicals, their mechanisms of action, extraction methods, pharmaceutical applications, and future perspectives are comprehensively discussed.

2. Plant-Based Bioactive Compounds

Medicinal plants synthesize a wide range of bioactive secondary metabolites that play a significant role in plant defense mechanisms against microbial pathogens, environmental stress, and herbivorous organisms. These naturally occurring compounds possess remarkable pharmacological properties and have gained substantial attention in antimicrobial and antifungal drug discovery. Unlike synthetic antimicrobial agents, plant-derived compounds often exhibit multitarget activities, reduced toxicity, and environmentally sustainable characteristics. The chemical diversity of phytochemicals provides immense opportunities for identifying novel therapeutic agents capable of combating multidrug-resistant pathogens [4]. Among the major classes of phytochemicals, alkaloids represent an important group of nitrogen-containing compounds with broad biological activities. Alkaloids such as berberine, quinine, morphine, and sanguinarine have demonstrated strong antimicrobial potential against both Gram-positive and Gram-negative bacteria as well as pathogenic fungi. These compounds exert their antimicrobial effects through inhibition of DNA replication, interference with metabolic enzymes, disruption of membrane integrity, and suppression of protein synthesis. Several alkaloids also exhibit synergistic interactions with conventional antibiotics, thereby enhancing antimicrobial efficacy and reducing resistance development.

Flavonoids are another major class of plant-derived polyphenolic compounds widely distributed in medicinal herbs, fruits, vegetables, and seeds. These compounds possess antioxidant, anti-inflammatory, antiviral, and antimicrobial properties. Flavonoids such as quercetin, kaempferol, catechin, and rutin have been extensively investigated for their ability to inhibit bacterial growth and fungal proliferation. Their antimicrobial activity is associated with membrane destabilization, inhibition of nucleic acid synthesis, suppression of energy metabolism, and interference with microbial adhesion and biofilm formation [5]. Due to their potent antioxidant activity, flavonoids also help reduce oxidative stress associated with infectious diseases.

Terpenoids constitute one of the largest and structurally diverse groups of plant secondary metabolites. Essential oils derived from aromatic medicinal plants are rich sources of terpenoids including thymol, menthol, limonene, eugenol, and carvacrol. These compounds exhibit strong antibacterial and antifungal activities primarily through disruption of microbial membrane permeability and inhibition of respiratory pathways. Terpenoids also interfere with ion transport and intracellular metabolic processes, resulting in microbial cell death [6]. Because of their volatility and natural origin, terpenoid-rich essential oils are increasingly used in pharmaceutical formulations, food preservation, and agricultural pathogen management.

Phenolic compounds represent another important category of plant bioactive molecules with broad-spectrum antimicrobial potential. Phenolic acids, tannins, and polyphenols are capable of disrupting microbial cell walls, denaturing proteins, and inhibiting extracellular microbial enzymes [7]. These compounds can also induce oxidative stress in microbial cells through the generation of reactive oxygen species. Phenolic-rich plant extracts have shown significant inhibitory activity against fungal pathogens such as Candida albicans, Aspergillus fumigatus, and several dermatophytes. Additionally, their antioxidant properties contribute to wound healing and tissue protection during microbial infections.

Tannins are high molecular weight polyphenolic compounds known for their protein-binding capabilities. They inhibit microbial growth by precipitating cellular proteins, inactivating enzymes, and disrupting membrane transport systems. Tannins are particularly effective against fungal pathogens and have been investigated for their role in controlling foodborne and agricultural fungal contamination [8]. Their natural preservative properties also support applications in pharmaceutical and food industries.

Saponins and glycosides are additional phytochemicals that exhibit substantial antimicrobial activities. Saponins possess surfactant-like properties that enable them to interact with membrane sterols, causing increased membrane permeability and eventual cell lysis. Glycosides contribute to antimicrobial activity through inhibition of essential microbial enzymes and metabolic pathways. Many medicinal plants rich in saponins and glycosides are traditionally used for the treatment of infectious diseases and inflammatory disorders [9]. Recent advances in phytochemical profiling, metabolomics, and chromatography have facilitated the identification of numerous plant-derived antimicrobial compounds with potential pharmaceutical applications. The growing interest in natural products research continues to expand the discovery of novel bioactive molecules capable of addressing antimicrobial resistance and promoting sustainable therapeutic development.

3. Mechanisms of Antimicrobial and Antifungal Action

Plant-derived bioactive compounds exert antimicrobial and antifungal activities through diverse and complex mechanisms that target multiple cellular pathways in microorganisms. Unlike many synthetic antimicrobial agents that act on a single molecular target, phytochemicals often exhibit multitarget actions, thereby reducing the likelihood of resistance development. This multifunctional nature has made plant bioactive compounds highly attractive candidates for the development of next-generation antimicrobial therapeutics [10]. One of the primary antimicrobial mechanisms involves disruption of microbial cell membrane integrity. Many phytochemicals, particularly terpenoids, essential oils, and saponins, interact directly with lipid bilayers of microbial membranes. This interaction alters membrane permeability, resulting in leakage of intracellular components such as proteins, nucleic acids, ions, and metabolic intermediates. Loss of membrane integrity ultimately leads to cellular dysfunction and microbial death. Essential oil components such as thymol, carvacrol, and eugenol are especially effective in destabilizing fungal and bacterial membranes. Another important mechanism involves inhibition of nucleic acid synthesis and replication. Certain alkaloids and flavonoids interfere with DNA gyrase, topoisomerase enzymes, and RNA polymerases, thereby suppressing microbial DNA replication and transcription processes. Inhibition of nucleic acid synthesis prevents microbial cell division and reduces pathogen proliferation. Berberine and quercetin are among the most studied phytochemicals exhibiting such activities against pathogenic microorganisms.

Plant bioactive compounds also inhibit protein synthesis by interacting with microbial ribosomes and translation-associated enzymes. By interfering with ribosomal function, these compounds suppress the production of essential proteins required for microbial growth, metabolism, and virulence. Inhibition of protein synthesis significantly impairs pathogen survival and contributes to antimicrobial effectiveness [11]. Biofilm inhibition represents another critical mechanism of plant-derived antimicrobial compounds. Biofilms are structured microbial communities embedded within extracellular polymeric substances that protect pathogens from antibiotics and host immune responses. Biofilm-associated infections are particularly difficult to treat and are major contributors to antimicrobial resistance. Several phytochemicals inhibit biofilm formation by disrupting quorum sensing pathways, reducing microbial adhesion, and suppressing extracellular polymer production. Flavonoids, phenolic compounds, and essential oils have demonstrated substantial antibiofilm activities against resistant bacterial strains. Induction of oxidative stress is also an important antimicrobial mechanism exhibited by many phytochemicals. Certain plant compounds stimulate the production of reactive oxygen species (ROS) within microbial cells. Elevated ROS levels cause oxidative damage to proteins, lipids, nucleic acids, and cellular organelles, leading to apoptosis or necrosis of microbial cells. Oxidative stress-mediated antimicrobial activity has been widely reported for phenolic compounds and nanoparticle-associated phytochemicals. In fungal pathogens, plant-derived compounds additionally interfere with ergosterol biosynthesis, mitochondrial function, and fungal cell wall synthesis. Ergosterol is an essential component of fungal cell membranes, and disruption of its biosynthesis compromises membrane stability and fungal viability. Several essential oils and phenolic compounds have shown potent antifungal activity through this mechanism.

Recent studies have also highlighted the synergistic interactions between phytochemicals and conventional antibiotics. Plant bioactive compounds may enhance antibiotic penetration, inhibit resistance enzymes, or suppress microbial efflux pumps, thereby restoring the effectiveness of conventional antimicrobial agents against resistant strains. Such synergistic approaches represent promising strategies for overcoming multidrug resistance and improving therapeutic outcomes, the broad-spectrum and multitarget antimicrobial mechanisms of plant-derived bioactive compounds support their growing importance in sustainable antimicrobial and antifungal drug discovery.

4. Extraction and Isolation Techniques of Plant Bioactive Compounds

Efficient extraction and isolation of bioactive compounds are essential steps in the development of plant-based antimicrobial and antifungal therapeutics. The biological activity of phytochemicals largely depends on the extraction method, solvent polarity, temperature, extraction duration, and plant material used. Appropriate extraction techniques improve the yield, purity, and stability of active compounds while preserving their pharmacological properties [13]. Conventional extraction methods such as maceration, decoction, infusion, percolation, and Soxhlet extraction have been widely used for isolating phytochemicals from medicinal plants. Maceration involves soaking plant materials in suitable solvents at room temperature for extended periods, allowing diffusion of bioactive compounds into the solvent. Decoction and infusion are commonly employed in traditional medicine systems for extracting water-soluble compounds. Soxhlet extraction is one of the most commonly used laboratory techniques and enables continuous extraction of phytochemicals using organic solvents such as ethanol, methanol, acetone, and hexane. Although conventional methods are simple and cost-effective, they often require large solvent volumes, prolonged extraction time, and high energy consumption. To overcome these limitations, advanced extraction technologies have been developed to improve extraction efficiency and sustainability. Ultrasound-assisted extraction utilizes ultrasonic waves to disrupt plant cell walls and enhance solvent penetration, thereby increasing extraction yield within shorter time periods. Microwave-assisted extraction employs microwave energy to heat intracellular moisture rapidly, resulting in improved release of phytochemicals from plant tissues.

Supercritical fluid extraction, particularly using supercritical carbon dioxide, has gained considerable importance due to its non-toxic, environmentally friendly, and solvent-free characteristics. This method is highly efficient for extracting thermolabile and non-polar compounds such as essential oils and terpenoids. Enzyme-assisted extraction further enhances phytochemical recovery through enzymatic degradation of plant cell wall components. Following extraction, chromatographic techniques such as thin-layer chromatography (TLC), high-performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), and liquid chromatography-mass spectrometry (LC-MS) are commonly used for separation, purification, and identification of bioactive compounds. These analytical approaches facilitate characterization of phytochemicals and support pharmaceutical standardization [14]. Recent developments in metabolomics, bioinformatics, and computational chemistry have further accelerated the identification of novel plant-derived antimicrobial compounds. Sustainable extraction approaches focusing on reduced solvent consumption, low energy requirements, and environmentally safe processes are increasingly emphasized in modern pharmaceutical research.

5. Plant-Based Antimicrobial Nanotechnology

Nanotechnology has emerged as a transformative field in pharmaceutical sciences and has significantly enhanced the therapeutic potential of plant-derived bioactive compounds. Plant-mediated nanotechnology combines phytochemicals with nanoscale materials to improve antimicrobial efficiency, bioavailability, targeted delivery, and therapeutic stability. Green synthesis of nanoparticles using plant extracts has gained considerable attention as an environmentally friendly alternative to conventional chemical and physical nanoparticle synthesis methods. Medicinal plant extracts contain diverse reducing and stabilizing agents such as flavonoids, phenolics, terpenoids, proteins, and sugars that facilitate nanoparticle synthesis [6]. These phytochemicals reduce metal ions into nanoparticles while simultaneously stabilizing the synthesized particles. Plant-mediated synthesis has been successfully applied for the production of silver, gold, zinc oxide, copper oxide, titanium dioxide, and iron oxide nanoparticles.

Silver nanoparticles synthesized using plant extracts are among the most extensively studied antimicrobial nanomaterials due to their strong antibacterial and antifungal properties. These nanoparticles exert antimicrobial activity through membrane disruption, oxidative stress induction, DNA damage, and inhibition of cellular respiration. Gold nanoparticles have also shown promising biomedical applications including drug delivery, biosensing, and targeted therapy. Plant-derived nanoparticles exhibit several advantages over conventional antimicrobial agents. Their nanoscale size increases surface area and enhances interaction with microbial cells, leading to improved antimicrobial efficacy. Nanoparticles also facilitate controlled and sustained drug release, thereby reducing dosage frequency and minimizing toxicity [3]. In addition, nanoparticle systems can improve solubility and bioavailability of poorly water-soluble phytochemicals.

Nanotechnology-based antimicrobial systems have found applications in wound healing, antimicrobial coatings, food packaging, water purification, and biomedical implants. Plant-mediated nanoparticles are increasingly incorporated into hydrogels, nanofibers, liposomes, and polymeric delivery systems for enhanced therapeutic performance. Despite their promising applications, concerns regarding nanoparticle toxicity, environmental impact, and long-term safety remain important challenges. Comprehensive toxicological evaluation and regulatory standardization are therefore essential for clinical translation of plant-based nanotherapeutics.

6. Applications in Sustainable Drug Discovery

Plant-derived bioactive compounds play an increasingly important role in sustainable antimicrobial and antifungal drug discovery. Natural products have historically served as major sources of pharmaceutical agents, and many modern antimicrobial drugs are directly or indirectly derived from plant metabolites. The growing prevalence of multidrug-resistant pathogens has renewed scientific interest in medicinal plants as reservoirs of novel therapeutic molecules. One of the major applications of phytochemicals involves the development of new antibacterial agents capable of combating resistant bacterial strains. Plant compounds such as flavonoids, alkaloids, terpenoids, and phenolics have demonstrated strong inhibitory activity against pathogens including Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Their multitarget mechanisms reduce the possibility of rapid resistance development [11]. Plant-derived antifungal compounds have also shown remarkable potential against fungal pathogens responsible for human, agricultural, and environmental diseases. Compounds such as thymol, eugenol, curcumin, cinnamaldehyde, and carvacrol exhibit significant activity against Candida albicans, Aspergillus species, and dermatophytic fungi. These natural antifungal agents disrupt fungal membranes, inhibit ergosterol biosynthesis, and interfere with spore germination. Another important application involves synergistic therapy using phytochemicals in combination with conventional antibiotics or antifungal drugs. Several plant compounds enhance antibiotic effectiveness by inhibiting microbial efflux pumps, reducing biofilm formation, or suppressing resistance-associated enzymes. Such combination therapies may help restore susceptibility in resistant microbial strains while lowering therapeutic dosages and adverse effects.

Plant bioactive compounds are also increasingly applied in agriculture as eco-friendly biopesticides, fungicides, and plant disease management agents. Unlike synthetic agrochemicals, plant-derived formulations are biodegradable, less toxic to non-target organisms, and environmentally sustainable. These applications support integrated pest management and sustainable agricultural practices. In pharmaceutical industries, phytochemicals are being incorporated into herbal formulations, nutraceuticals, topical creams, oral therapeutics, and functional foods. Advances in biotechnology, molecular docking, artificial intelligence, and high-throughput screening have accelerated the identification of plant-based lead compounds for future drug development.

7. Challenges and Limitations

Despite significant progress in plant-based antimicrobial drug discovery, several scientific, technical, and regulatory challenges continue to limit the clinical and industrial application of phytochemicals. One of the major limitations is the variability in phytochemical composition among medicinal plants. Environmental factors such as climate, soil conditions, geographical location, harvesting season, and storage conditions greatly influence the concentration and composition of bioactive compounds. Such variability complicates reproducibility and pharmaceutical standardization. Another major challenge involves the low bioavailability of many phytochemicals. Numerous plant-derived compounds exhibit poor aqueous solubility, instability, rapid metabolism, and limited absorption within the human body. These limitations reduce therapeutic effectiveness and restrict clinical applicability. Advanced drug delivery systems including nanoparticles, liposomes, micelles, and polymeric carriers are being explored to overcome these issues.

Toxicity and safety evaluation remain critical concerns in phytopharmaceutical development. Although medicinal plants are often considered safer than synthetic drugs, certain phytochemicals may exhibit cytotoxic, hepatotoxic, nephrotoxic, or genotoxic effects at higher concentrations or prolonged exposure. Comprehensive preclinical and clinical studies are therefore necessary to establish safety profiles and therapeutic dosage ranges. Lack of standardized extraction procedures and quality control protocols also presents substantial difficulties. Variations in extraction solvents, processing methods, and analytical techniques may lead to inconsistent pharmacological outcomes. Regulatory agencies require rigorous standardization, authentication, and quality assurance for commercialization of plant-derived therapeutics. Another important limitation is the relatively limited number of clinical trials evaluating plant-based antimicrobial compounds. Most available studies remain confined to in vitro or animal models, and translation into human therapeutics requires extensive clinical validation. Regulatory approval processes for herbal medicines and phytopharmaceuticals are often complex and vary significantly across countries. Intellectual property rights and biodiversity conservation issues further complicate commercialization of medicinal plant resources. Unsustainable harvesting of medicinal plants may threaten biodiversity and ecological balance. Therefore, sustainable cultivation practices, conservation strategies, and ethical bioprospecting approaches are essential for long-term utilization of plant resources.

9. Conclusion

Plant-derived bioactive compounds represent a promising and sustainable source of antifungal and antimicrobial agents for modern drug discovery. Their diverse chemical structures, broad-spectrum biological activities, and multitarget mechanisms make them valuable alternatives to synthetic antimicrobial drugs. Recent advances in phytochemistry, extraction technologies, nanotechnology, and molecular biology have expanded the therapeutic potential of medicinal plants. Green synthesis approaches utilizing plant extracts further support environmentally sustainable pharmaceutical development. Although challenges such as low bioavailability, toxicity evaluation, and regulatory limitations remain, continued interdisciplinary research may facilitate the successful translation of phytochemicals into clinically effective antimicrobial therapeutics. Plant-based bioactive compounds therefore offer significant opportunities for addressing antimicrobial resistance and developing safer, eco-friendly pharmaceutical products for future healthcare systems.

References

1. Angelini, P. (2024). Plant-derived antimicrobials and their crucial role in combating antimicrobial resistance. Antibiotics, 13(8), 746.
2. Dantas, T. D. S., Machado, J. C. B., Ferreira, M. R. A., & Soares, L. A. L. (2025). Bioactive plant compounds as alternatives against antifungal resistance in the Candida strains. Pharmaceutics, 17(6), 687.
3. Gonçalves, Ana C., Ana R. Pinto, André Cima, Eva Olo-Fontinha, Joana CL Martins, Juliana Garcia, André Lemos, Maria José Saavedra, Maria Manuela Pintado, and Maria José Alves. “Plant-derived bioactive compounds: one health perspective.” Applied Sciences 16, no. 1 (2025): 327.
4. El-Saadony, Mohamed T., Ahmed M. Saad, Dina Mostafa Mohammed, Sameh A. Korma, Mohammad Y. Alshahrani, Ahmed Ezzat Ahmed, Essam H. Ibrahim et al. “Medicinal plants: bioactive compounds, biological activities, combating multidrug-resistant microorganisms, and human health benefits-a comprehensive review.” Frontiers in immunology 16 (2025): 1491777.
5. Najmi, A., Javed, S. A., Al Bratty, M., & Alhazmi, H. A. (2022). Modern approaches in the discovery and development of plant-based natural products and their analogues as potential therapeutic agents. Molecules, 27(2), 349.
6. AlSheikh, H. M. A., Sultan, I., Kumar, V., Rather, I. A., Al-Sheikh, H., Tasleem Jan, A., & Haq, Q. M. R. (2020). Plant-based phytochemicals as possible alternative to antibiotics in combating bacterial drug resistance. Antibiotics, 9(8), 480.
7. Raghu, K. (2024). Plant based metabolites as innovative tools for controlling infectious agents and enhancing antimicrobial pharmacodynamic. Plant Science Review.
8. Mulat, Mulugeta, Riza Jane S. Banicod, Nazia Tabassum, Aqib Javaid, Abirami Karthikeyan, Geum-Jae Jeong, Young-Mog Kim, Won-Kyo Jung, and Fazlurrahman Khan. “Multiple strategies for the application of medicinal plant-derived bioactive compounds in controlling microbial biofilm and virulence properties.” Antibiotics 14, no. 6 (2025): 555.
9. Anand, U., Jacobo-Herrera, N., Altemimi, A., & Lakhssassi, N. (2019). A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites, 9(11), 258.
10. Chaachouay, N., & Zidane, L. (2024). Plant-derived natural products: a source for drug discovery and development. Drugs and Drug Candidates, 3(1), 184-207.
11. Zarroug, S. H., Bajaman, J. S., Hamza, F. N., Saleem, R. A., & Abdalla, H. K. (2023). Caenorhabditis elegans as an in vivo model for the discovery and development of natural plant-based antimicrobial compounds. Pharmaceuticals, 16(8), 1070.
12. Nguyen, N. T. T., Nguyen, L. M., Nguyen, T. T. T., Nguyen, T. T., Nguyen, D. T. C., & Tran, T. V. (2022). Formation, antimicrobial activity, and biomedical performance of plant-based nanoparticles: a review. Environmental Chemistry Letters, 20(4), 2531-2571.
13. Esmaeili, A., Saleh, I., & Abu-Dieyeh, M. H. (2025). Antifungal potential of plant-based extracts against Candida species: values, safety concerns, and possible applications. Phytochemistry Reviews, 24(6), 5801-5844.
14. Kumar, A., Kujur, A., Yadav, A., Pratap, S., & Prakash, B. (2019). Optimization and mechanistic investigations on antifungal and aflatoxin B1 inhibitory potential of nanoencapsulated plant-based bioactive compounds. Industrial crops and products, 131, 213-223.